Theranos Says Investors Can't Sue Over Blood Tests
Beleaguered blood-testing startup Theranos and its executives urged a California federal judge Wednesday to toss a putative securities class action alleging they misled investors about the accuracy of Theranos' tests, saying...To view the full article, register now.
Already a subscriber? Click here to view full article